Reduced expression of Basigin gene products in response to chronic inflammation may contribute to vision loss

Document Type

Article

Publication Date

1-1-2023

Subject Area

Animals; Mice; Basigin (genetics); Endothelial Cells; Lipopolysaccharides (metabolism); Retina (metabolism); Inflammation (genetics, metabolism); RNA (metabolism)

Abstract

Chronic inflammation of the retina, like that of diabetic retinopathy, disrupts the blood-retina barrier (BRB). Disruption of the BRB increases vascular permeability and leads to vision loss. Basigin gene products, cell-adhesion molecules and members of the immunoglobulin superfamily, are expressed on endothelial cells, photoreceptor cells and Müller glial cells. Basigin variant-1 on photoreceptors interacts with Basigin variant-2 on Müller glial cells and to rod-derived cone viability factor (RdCVF) to form metabolic support mechanisms necessary for the survival of photoreceptor neurons. The goal of the current study was to determine the gene expression changes of Basigin gene products in ex vivo neonatal, adolescent, and adult retina when exposed to an inflammatory insult in acute and chronic phases. Retinas extracted from mice at postnatal day (P) 7, 30, and 180 were incubated with either phosphate-buffered saline (PBS), as a control, or lipopolysaccharide (LPS), an endotoxin, for 3, 6, 12, or 24 h. RNA was then extracted and Basigin gene products were quantified by qPCR. Analyses indicate both gene products are influenced by LPS exposure in a time and age dependent manner. Specifically, P180 retinas exposed to LPS showed significant decreases in both Basigin gene products, suggesting older retinas may be susceptible to chronic inflammation and subsequent vision loss.

Publication Title

Biochemical and biophysical research communications

Volume

638

First Page

163

Last Page

167

Digital Object Identifier (DOI)

10.1016/j.bbrc.2022.11.074

PubMed ID

36459880

E-ISSN

1090-2104

Language

eng

Link to Full Text

Share

COinS